Table 8.
The changes of SF-36 scores before and after the intervention (Wilcoxon two-sample rank sum test)
| Dimension | Mega MSM (n=49) |
Placebo (n=50) |
z | P |
|---|---|---|---|---|
| Average rank | Average rank | |||
|
| ||||
| PF | 65.41 | 34.90 | -5.878 | 0.000 |
| RP | 59.17 | 41.01 | -4.333 | 0.000 |
| BP | 62.26 | 37.99 | -5.185 | 0.000 |
| GH | 51.53 | 48.50 | -1.181 | 0.238 |
| VT | 51.47 | 48.56 | -1.134 | 0.257 |
| SF | 56.53 | 43.60 | -3.265 | 0.001 |
| RE | 49.50 | 50.49 | -0.557 | 0.564 |
| MH | 51.93 | 48.11 | -1.265 | 0.206 |
| HT | 50.01 | 49.99 | -0.014 | 0.989 |
| PCS | 66.28 | 34.05 | -6.067 | 0.000 |
| MCS | 54.67 | 45.42 | -2.133 | 0.033 |
| Total score | 66.01 | 34.01 | -5.857 | 0.000 |